Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · IEX Real-Time Price · USD
1.000
+0.150 (17.65%)
At close: Apr 26, 2024, 4:00 PM
0.940
-0.060 (-6.00%)
After-hours: Apr 26, 2024, 7:59 PM EDT
Tevogen Bio Holdings Market Cap
Tevogen Bio Holdings has a market cap or net worth of $164.61 million as of April 26, 2024. Its market cap has decreased by -1.55% in one year.
Market Cap
164.61M
Enterprise Value
255.52M
1-Year Change
-1.55%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since November 4, 2021, Tevogen Bio Holdings's market cap has decreased from $421.50M to $164.61M, a decrease of -60.95%. That is a compound annual growth rate of -31.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2024 | 130.30M | -43.32% |
| Apr 24, 2024 | 229.90M | -9.09% |
| Apr 23, 2024 | 252.90M | -1.17% |
| Apr 22, 2024 | 255.90M | -9.74% |
| Apr 19, 2024 | 283.50M | -12.74% |
| Apr 18, 2024 | 324.90M | -7.22% |
| Apr 17, 2024 | 350.20M | -3.18% |
| Apr 16, 2024 | 361.70M | 0.44% |
| Apr 15, 2024 | 360.10M | -4.10% |
| Apr 12, 2024 | 375.50M | -0.79% |
| Apr 11, 2024 | 378.50M | 0.80% |
| Apr 10, 2024 | 375.50M | 4.28% |
| Apr 9, 2024 | 360.10M | -12.98% |
| Apr 8, 2024 | 413.80M | -7.53% |
| Apr 5, 2024 | 447.50M | -14.11% |
| Apr 4, 2024 | 521.00M | 29.76% |
| Apr 3, 2024 | 401.50M | -11.19% |
| Apr 2, 2024 | 452.10M | -8.56% |
| Apr 1, 2024 | 494.40M | -13.97% |
| Mar 28, 2024 | 574.70M | 8.07% |
| Mar 27, 2024 | 531.80M | -10.65% |
| Mar 26, 2024 | 595.20M | -2.17% |
| Mar 25, 2024 | 608.40M | -9.38% |
| Mar 22, 2024 | 671.40M | 2.60% |
| Mar 21, 2024 | 654.40M | -3.82% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compugen | 171.90M |
| Capricor Therapeutics | 170.43M |
| Inventiva | 170.21M |
| Greenwich LifeSciences | 168.96M |
| Alpha Tau Medical | 167.56M |
| Butterfly Network | 164.08M |
| scPharmaceuticals | 161.88M |
| Inogen | 159.65M |